Cтандартизованный экстракт хмеля в облегчении симтомов менопаузы

R. Erkkola, S. Vervarcke, S. Vansteelandt, P. Rompotti, D. DeKeukeleire, A. Heyerick

Abstract


Интерес к применению фитоэстрогенов при ведении пациентов с климактерическими жалобами с каждым годом возрастает. Фитоэстрогены – это преимущественно нестероидные полифенольные соединения растительного происхождения, функционально имитирующие деятельность человеческого эстрогена и 17β-эстрадиола. К наиболее насыщенным источникам фитоэстрогенов относят сою и красный клевер (изофлавоны), семена льна (лигнаны) и хмель (пренилфлавоноиды) (Cos et al., 2003).

GOST Style Citations


1. Atkinson C., Frankenfeld C.L., Lampe J.W. 2005. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. 230, 155-170.

2. Bolca S., Possemiers S., Maervoet V., Huybrechts I., Heyerick A., Vervarcke S., Depypere H., DeKeukeleire D., Bracke M., DeHenauw S., Verstraete W., Van deWiele T. 2007. Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy postmenopausal Caucasian women. Br. J. Nutr. 98, 950-959.

3. Booth N.L., Piersen C.E., Banuvar S., Geller S.E., Shulman L.P., Farnsworth N.R. 2006. Clinical studies of red clover (Trifoliumpratense) dietary supplements in menopause: a literature review. Menopause 13, 251-264.

4. Borrelli F., Ernst E. 2008. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol. Res. 58, 8-14.

5. Bowe J., Li X.F., Kinsey-Jones J., Heyerick A., Brain S., Milligan S., O’Byrne K. 2006. The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in ananimal model of menopausal hot flushes. J. Endocrinol. 191, 399-405.

6. Christoffel J., Rimoldi G., Wuttke W. 2006. Effects of 8-prenylnaringeninon the hypothalamo-pituitaryuterine axis in rat safter3-monthtreatment. J. Endocrinol.188, 397-405.

7. Clerici C., Setchell K.D.R., Battezzati P.M., Pirro M., Giuliano V., Asciutti S., Castellani D., Nardi E., Sabatin G., Orlandi S., Baldoni M., Morelli O., Mannarino, E. Morelli A. 2007. Pasta naturallyen riched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J. Nutr. 137, 2270-2278.

8. Col N.F., Guthrie J.R., Politi M., Dennerstein L. 2009. Duration of vasomotor symptoms inmiddle-aged women: a longitudinal study. Menopause 16, 453-457.

9. Cos P., De Bruyne T., Apers S., Berghe D.V., Pieters L., Vlietinck A.J. 2003. Phytoestrogens: recent developments. Planta Med.69, 589-599.

10. Fitzmaurice G., Laird N., Ware J. 2004. Applied Longitudinal Analysis. Wiley.

11. Heyerick A., Vervarcke S., Depypere H., Bracke M., De Keukeleire D. 2006. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54, 164-175.

12. Holzbeierlein J.M., McIntosh J., Thrasher J.B. 2005. The role of soy phytoestrogens in prostate cancer. Curr. Opin. Urol. 15, 17-22.

13. Humpel M., Isaksson P., Schaefer O., Kaufmann, U., Ciana P., Maggi A ., Schleuning W.D. 2005. Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J. Steroid Biochem. Mol. Biol.

14. Huntley A.L., Ernst E. 2004. Soy for the treatment of perimenopausal symptoms – a systematic review. Maturitas 47, 1-9.

15. Koetter U., Schrader E., Kaufeler R., Brattstrom A. 2007. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze91019) in patients suffering fromnon-organic sleep disorder. Phytother. Res. 21, 847-851.

16. Krebs E.E., Ensrud K.E., MacDonald R., Wilt T.J. 2004. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet. Gynecol. 104, 824-836.

17. Kronenberg F., Fugh-Berman A. 2002. Complementary and alternative medicine for menopausal symptoms: are view of randomized, controlled trials. Ann. Intern. Med. 137, 805-813.

18. Kupperman H.S., Blatt M.H.G., Wiesbader H., Filler W. 1953. Comparative evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J. Clin. Endocrinol. Metab. 13, 688-703.

19. Lethaby A.E., Brown J., Marjoribanks J., Kronenberg F., Roberts H., Eden J. 2007. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst. Rev.

20. Messina M., Ho S., Alekel D.L. 2004. Skeletal benefits of soy isoflavones: a review of the clinical trial and epiderniologic data. Curr. Opin. Clin. Nutr. Metab. Care 7, 649-658.

21. Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., De Keukeleire D. 1999. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 84, 2249-2252.

22. Moriyama C.K., Oneda B., Bernardo F.R., Cardoso C.G., Forjaz C.L.M., Abrahao S.B., Mion D., Fonseca A.M., Tinucci T. 2008. A randomized, placebo- controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women. Menopause 15, 613-618.

23. Nahas E.A.P., Nahas-Neto J., Orsatti F.L., Carvalho E.P., Oliveira M., Dias R. 2007. Efficacy and safety of a soy isoflavone extract in postmenopausal women: A randomized, double-blind, and placebo-controlled study. Maturitas 58, 249-258.

24. Nielsen I.L.F., Williamson G. 2007. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr. Cancer 57, 1-10.

25. Overk C.R., Guo J., Chadwick L.R., Lantvit D.D., Minassi A., Appendino G., Chen S.N., Lankin D.C., Farnsworth N.R., Pauli G.F., van Breemen R.B., Bolton,J.L. 2008. In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin. Chem. Biol. Interact. 176, 30-39.

26. Palacios S., Pornel B., Bergeron C., Chantre P., Nogales F., Aubert L ., Vazquez F., Eden J., Mares P. 2007. Endometrial safety assessment of a specific and standardized soy extract according to international guidelines. Menopause 14, 1006-1011.

27. Panay N. 2007. Integrating phytoestrogens with prescription medicines – A conservative clinical approach to vasomotor symptom management. Maturitas 57, 90-94.

28. Possemiers S., Bolca S., Eeckhaut E., Depypere H., Verstraete W. 2007. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Micro- biol. Ecol. 61, 372-383.

29. Possemiers S., Bolca S., Grootaert C., Heyerick A., Decroos K., Dhooge W., De Keukeleire D., Rabot S., Verstraete W., Van de Wiele T. 2006. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J. Nutr. 136, 1862-1867.

30. Possemiers S., Heyerick A., Robbens V., De Keukeleire D., Verstraete W. 2005. Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; Conversion of isoxanthohumol into 8-prenylnaringenin. J. Agric. Food Chem. 53, 6281-6288.

31. Rad M., Humpel M., Schaefer O., Schoemaker R.C., SchleuningW.D., Cohen A.F., Burggraaf J. 2006. Pharmacokinetics and systemic endocrine effects of the

phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br. J. Clin. Pharmacol. 62, 288-296.

32. Reed S.D., Newton K.M., LaCroix A.Z., Grothaus L.C., Grieco V.S., Ehrlich K. 2008. Vaginal, endometrial, and reproductive hormone findings: randomized, placebocontrolled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 15, 51-58.

33. Rodstrom K., Bengtsson C., Lissner L., Milsom I., Sundh V., Bjorkelund C. 2002. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 9, 156-161.

34. Rong H., Zhao Y., Lazou K., De Keukeleire D., Milligan S.R., Sandra P. 2000. Quantitation of 8-prenylnaringenin, a novel phytoestrogen in hops (Humulus lupulus L.), hop products, and beers, by benchtop HPLC-MS using electrospray ionization. Chromatographia 51, 545-552.

35. Santoro N.F., Clarkson T.B., Freedman R.R., Fugh-Berman A.J., Loprinzi C.L., Reame N.K., Board Trustees N.A.M.S. 2004. Treatment of menopauseassociated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 11, 11-33.

36. Schneider H.P.G., Rosemeier H.P., Schnitker J., Gerbsch S., Turck R. 2000. Application and factor analysis of the menopause rating scale [MRS] in a post- marketing surveillance study of Climen (R). Maturitas 37, 113-124.

37. Tamura M. 2006. Effects of intestinal flora on the metabolism and absorption of isoflavones. Japan Agri. Res. Quart. 40, 45-50.

38. Tempfer C.B., Bentz E.K., Leodolter S., Tscherne G., Reuss F., Cross H.S., Huber J.C. 2007. Phytoestrogens in clinical practice: a review of the literature. Fertil. Steril. 87, 1243-1249.

39. Valiati B., Capp E., Edelweiss M.I., de Freitas F.M., Wender M.C.O. 2009. Effect of raloxifene and low-dose percutaneous 17 beta-estradiol on menopause symptoms and endometrium – a randomized controlled trial. Maturitas 62, 81-84.

40. Verbeke G., Molenberghs G. 2000. Linear Mixed Models for Longitudinal Data. Springer-Verlag.

41. Wu A.H., Yu M.C., Tseng C.C., Pike M.C. 2008. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 98, 9-14.

42. Ye Y.B., Tang X.Y., Verbruggen M.A., Su Y.X. 2006. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women – a single-blind randomized, placebo-controlled trial. Eur. J. Nutr. 45, 327-334.





DOI: http://dx.doi.org/10.18370/2309-4117.2011.2.72-78

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)